S1 Fig. PCR amplicons from cattle- and buffalo-derived T. parva parasites from East and
southern Africa. (a) p67 PCR amplicons from buffalo-derived T. parva parasites from clinical
cases of Corridor disease (CD) and non-clinical T. parva-positive cases from South Africa
(SA); (b) p67 PCR amplicons from buffalo-derived T. parva parasites originating from buffalo
in Hluhluwe-iMfolozi Park, KwaZulu-Natal; (c) p67 PCR amplicons from cattle-derived T.
parva parasites originating from cattle in Mbarara in Western Uganda. 1kb DNA ladder
(#SM0311, ThermoFisher Scientific, Waltham, MA USA) was used in (a), 100bp plus DNA
ladder (#SM0321, ThermoFisher Scientific, Waltham, MA USA) was used in (b) and (c). SA—
South Africa; CD—Corridor disease; M—molecular weight marker.
S1 Table. The Ct values of samples from active clinical cases of Corridor disease and nonclinical
T. parva-positive cases collected from Mpumalanga province in South Africa.
S2 Table. Predicted protein sequence alignment of allele type 2 identified in T. parva parasites
from cattle and buffalo.
S3 Table. Predicted protein sequence alignment of allele type 3 identified in T. parva parasites
from cattle and buffalo.
S4 Table. Predicted protein sequence alignment of allele type 4 identified in T. parva parasites
from cattle and buffalo.
S5 Table. Estimates of the evolutionary divergence between sequences of allele type 1 from
T. parva parasites from East and Southern Africa.
S6 Table. Taxonomic metadata detailing the grouping of p67 allele types from T. parva
parasites from East and Southern Africa.